Evidence map›Paper›PMID 25759497›Full record

ArticlemBio2015

Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing.

Md Tauqeer Alam, Timothy D Read, Robert A Petit, Susan Boyle-Vavra, Loren G Miller, Samantha J Eells, Robert S Daum, Michael Z David

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Phylodynamic signatures in the emergence of community-associated MRSA.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Md Tauqeer AlamDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Timothy D Readmdavid@medicine.bsd.uchicago.edu tread@emory.edu.
Robert A PetitDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Susan Boyle-VavraDepartment of Pediatrics, Section of Infectious Diseases, University of Chicago, Chicago, Illinois, USA.
Loren G MillerDepartment of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
Samantha J EellsDepartment of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
Robert S DaumDepartment of Pediatrics, Section of Infectious Diseases, University of Chicago, Chicago, Illinois, USA.
Michael Z Davidmdavid@medicine.bsd.uchicago.edu tread@emory.edu.
Emory University · USUniversity of Chicago · USHarbor–UCLA Medical Center · USUCLA Medical Center · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Spread of Community-Acquired MRSA Among Household ContactsR01AI067584 · NIAID · UNIVERSITY OF CHICAGO · PI DAUM, ROBERT S. · 2007 to 2010
$2.4M
Genetics of vancomycin intermediate resistance in S. aureusR56AI091827 · NIAID · EMORY UNIVERSITY · PI READ, TIMOTHY D. · 2011 to 2011
$740k
Recurrent MRSA Infections: A Study of Risk Factors and Molecular EpidemiologyK23AI095361 · NIAID · UNIVERSITY OF CHICAGO · PI DAVID, MICHAEL ZDENEK · 2011 to 2015
$633k
NCATS NIH HHS UL1 TR000430NIAID NIH HHS AI067584-01NIAID NIH HHS AI091827NIAID NIH HHS AI095361-01NIAID NIH HHS K23 AI095361NIAID NIH HHS R01 AI067584NIAID NIH HHS R56 AI091827
6 · The paper itself

Abstract

unlabelledMethicillin-resistant Staphylococcus aureus (MRSA) USA300 is a successful S. aureus clone in the United States and a common cause of skin and soft tissue infections (SSTIs). We performed whole-genome sequencing (WGS) of 146 USA300 MRSA isolates from SSTIs and colonization cultures obtained from an investigation conducted from 2008 to 2010 in Chicago and Los Angeles households that included an index case with an S. aureus SSTI. Identifying unique single nucleotide polymorphisms (SNPs) and analyzing whole-genome phylogeny, we characterized isolates to understand transmission dynamics, genetic relatedness, and microevolution of USA300 MRSA within the households. We also compared the 146 USA300 MRSA isolates from our study with the previously published genome sequences of the USA300 MRSA isolates from San Diego (n = 35) and New York City (n = 277). We found little genetic variation within the USA300 MRSA household isolates from Los Angeles (mean number of SNPs ± standard deviation, 17.6 ± 35; π nucleotide diversity, 3.1 × 10(-5)) or from Chicago (mean number of SNPs ± standard deviation, 12 ± 19; π nucleotide diversity, 3.1 × 10(-5)). The isolates within a household clustered into closely related monophyletic groups, suggesting the introduction into and transmission within each household of a single common USA300 ancestral strain. From a Bayesian evolutionary reconstruction, we inferred that USA300 persisted within households for 2.33 to 8.35 years prior to sampling. We also noted that fluoroquinolone-resistant USA300 clones emerged around 1995 and were more widespread in Los Angeles and New York City than in Chicago. Our findings strongly suggest that unique USA300 MRSA isolates are transmitted within households that contain an individual with an SSTI. Decolonization of household members may be a critical component of prevention programs to control USA300 MRSA spread in the United States. IMPORTANCE: USA300, a virulent and easily transmissible strain of methicillin-resistant Staphylococcus aureus (MRSA), is the predominant community-associated MRSA clone in the United States. It most commonly causes skin infections but also causes necrotizing pneumonia and endocarditis. Strategies to limit the spread of MRSA in the community can only be effective if we understand the most common sources of transmission and the microevolutionary processes that provide a fitness advantage to MRSA. We performed a whole-genome sequence comparison of 146 USA300 MRSA isolates from Chicago and Los Angeles. We show that households represent a frequent site of transmission and a long-term reservoir of USA300 strains; individuals within households transmit the same USA300 strain among themselves. Our study also reveals that a large proportion of the USA300 isolates sequenced are resistant to fluoroquinolone antibiotics. The significance of this study is that if households serve as long-term reservoirs of USA300, household MRSA eradication programs may result in a uniquely effective control method.

Indexed as

Evolution, MolecularFamily CharacteristicsGenetic VariationCluster AnalysisDNA, BacterialGenome, BacterialGenotypeMethicillin-Resistant Staphylococcus aureusPolymorphism, Single NucleotideSequence Analysis, DNAStaphylococcal InfectionsUnited StatesDNA, Bacterial

Identifiers

PMID25759497
PMCPMC4453535
OpenAlexW2091321829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.